CHLOROPTIC S.O.P. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chloroptic S.o.p., and what generic alternatives are available?
Chloroptic S.o.p. is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in CHLOROPTIC S.O.P. is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
Summary for CHLOROPTIC S.O.P.
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Patent Applications: | 4,151 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLOROPTIC S.O.P. at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROPTIC S.O.P.
US Patents and Regulatory Information for CHLOROPTIC S.O.P.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CHLOROPTIC S.O.P. | chloramphenicol | OINTMENT;OPHTHALMIC | 061187-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |